Although it is primarily recognized as a central pillar in cancer treatment, radiotherapy also has a valuable therapeutic role in the management of certain non-oncological (benign) conditions. In these situations, the goal is not to destroy a malignant tumor, but to use the energy of radiation to modulate inflammation, stop excessive cellular proliferation, or induce the regression of certain vascular malformations.

The use of radiotherapy in benign pathology requires rigorous patient selection. The therapeutic decision is not a routine one, but the result of a careful analysis of the balance between clinical benefit and each individual’s medical history.

Mechanism of action in benign pathology

Unlike the high doses used in oncology, much lower-dose protocols are used in benign conditions. These doses are able to inhibit the accelerated division of cells that produce excess collagen or of those that form abnormal blood vessels, without affecting the overall integrity of healthy tissue.

Keloids and hypertrophic scars

Keloids are scars that grow beyond the limits of the initial wound and are often painful, pruritic (itchy), and aesthetically distressing. Because of the high recurrence rate after simple surgical excision, radiotherapy is used as a strategic adjuvant treatment.

How radiotherapy helps: When administered immediately after surgery (usually within the first 24 to 48 hours), radiotherapy prevents the excessive activity of fibroblasts — the cells responsible for collagen production. In this way, the risk of scar recurrence is significantly reduced.

Hemangiomas and vascular malformations

Hemangiomas are clusters of blood vessels that may appear in various areas of the body. Although most do not require treatment, there are complex cases in which the location (for example, near the eyes or airways) or rapid progression makes intervention necessary.

In specific situations, radiotherapy can induce sclerosis (closure) of abnormal blood vessels, leading to the halt of growth or even shrinkage of the lesion. The indication is established strictly within the multidisciplinary team, when other methods (medical treatment or laser therapy) are not applicable.

Other applications: Prevention of heterotopic ossification

Another important use of benign radiotherapy is the prevention of bone formation in abnormal locations (heterotopic ossification), frequently encountered after hip surgery or severe trauma. A single perioperative dose of radiotherapy can block the transformation of stem cells into bone cells in unwanted locations.

Radiotherapy for benign conditions represents a highly refined medical solution, in which the minimum dose is calculated to achieve maximum functional impact, restoring patient comfort without repeated surgical interventions.

Criteria for specialist evaluation

Radiotherapy is not the first treatment option in benign conditions, but it becomes a solution worth considering when:

The condition has a history of recurrence after conventional treatments;
Symptoms (pain, limitation of movement, bleeding) severely affect quality of life;
Other interventions are contraindicated because of the lesion’s location;
There is a clear recommendation from a specialist physician (dermatologist, orthopedist, or surgeon).

Specialist evaluation within the radiotherapy department makes it possible to establish a personalized plan that provides long-term safety and optimal aesthetic or functional results.